Valuation: Renata PLC

Market Cap 53.08B 432M 370M 347M 317M 598M 41.17B 604M 4.09B 1.59B 20.77B 1.62B 1.59B 68.79B P/E 2026 *
18.9x
P/E 2027 * 12.8x
Enterprise Value 53.08B 432M 370M 347M 317M 598M 41.17B 604M 4.09B 1.59B 20.77B 1.62B 1.59B 68.79B EV / Sales 2026 *
1.12x
EV / Sales 2027 * 0.96x
Free-Float
17.05%
Yield 2026 *
1.23%
Yield 2027 * 3.15%
1 day-0.37%
1 week-1.34%
Current month-1.57%
1 month-2.38%
3 months+11.79%
6 months+1.03%
Current year+18.12%
1 week 462.4
Extreme 462.4
470
1 month 458
Extreme 458
483.2
Current year 381.8
Extreme 381.8
488
1 year 372
Extreme 372
547
3 years 372
Extreme 372
1,217.9
5 years 372
Extreme 372
1,289.72
10 years 372
Extreme 372
1,289.72
Manager TitleAgeSince
Chief Executive Officer - 01/01/2002
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 01/01/2002
Chairman 84 -
Director/Board Member - 27/08/2013
Change 5-day change 1-year change 3-year change Capi.($)
-0.37%-1.34%-2.75%-62.00% 433M
-1.06%+0.65%+77.42%+122.82% 1,111B
+0.53%+0.75%+53.10%+64.29% 658B
+0.48%+2.65%+28.06%+81.19% 467B
+0.92%+3.57%+43.82%+44.21% 369B
+1.25%+2.21%+26.77%+43.05% 301B
+3.02%+5.68%+4.24%+17.04% 256B
-0.36%+3.99%+53.31%+72.49% 240B
+2.86%+3.86%-16.20%-51.83% 207B
+1.38%+3.72%+30.33%+93.56% 182B
Average +0.86%+2.56%+29.81%+42.48% 379.14B
Weighted average by Cap. +0.43%+2.20%+45.99%+72.28%

Financials

2026 *2027 *
Net sales 47.45B 386M 331M 310M 283M 534M 36.8B 540M 3.66B 1.42B 18.57B 1.45B 1.42B 61.49B 55.08B 448M 384M 360M 329M 620M 42.72B 626M 4.24B 1.65B 21.56B 1.68B 1.65B 71.38B
Net income 2.81B 22.87M 19.6M 18.37M 16.78M 31.66M 2.18B 31.97M 217M 84.34M 1.1B 85.89M 84.02M 3.64B 4.39B 35.7M 30.59M 28.66M 26.18M 49.41M 3.4B 49.9M 338M 132M 1.72B 134M 131M 5.69B
Net Debt - -
Logo Renata PLC
Renata PLC is a Bangladesh-based pharmaceutical company. The Company is engaged in the manufacturing, marketing and distribution of pharmaceuticals, animal health products, oncology-based products, agro-based products, poultry products, and consumer products. It operates in several modalities, such as oral solids dosage forms, which include tablets, capsules, OROS, oral dispersible tablets; soft gels injectables, which include hormone injectables, general injectables and oncology injectables; inhalers, which include DPI and MDI, and nutraceutical products. Its offering includes anthelmintic, live vaccines, nutrition products, vitamins & minerals, anti-gout, anti-spasmodic, and anti-allergic. The Company has approximately 14 manufacturing facilities spread over three manufacturing sites.
Employees
8,366
Date Price Change Volume
25/08/26 BDT 462.80 -0.37% 15,362
24/08/26 BDT 464.50 -0.15% 29,763
23/08/26 BDT 465.20 -0.19% 45,627
20/08/26 BDT 466.10 -0.24% 10,448
19/08/26 BDT 467.20 -0.41% 28,450
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
462.80BDT
Average target price
615.05BDT
Spread / Average Target
+32.90%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RENATA Stock